Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-17-066693

President & CEO sold 104,131 shares at an average $1.15 ($119,325)

From the SEC's structured data for this filing

Trades in this filing

Mohan Pankaj · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-12-18 Sale : show line 1 in the form −20,523 $1.17 $24,012 7,254,838 D
2017-12-19 Sale : show line 2 in the form −83,608 $1.14 $95,313 7,171,230 D
Open-market sales · 104,131 sh · avg $1.15 · $119,325
Loading xslF345X03/doc4.xml…